Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242082761> ?p ?o ?g. }
- W4242082761 endingPage "573" @default.
- W4242082761 startingPage "567" @default.
- W4242082761 abstract "To determine whether dronabinol administered alone or with megestrol acetate was more, less, or equal in efficacy to single-agent megestrol acetate for palliating cancer-associated anorexia.Four hundred sixty-nine assessable advanced cancer patients were randomized to (1) oral megestrol acetate 800 mg/d liquid suspension plus placebo, (2) oral dronabinol 2.5 mg twice a day plus placebo, or (3) both agents. Eligible patients acknowledged that loss of appetite or weight was a problem and reported the loss of 5 pounds or more during 2 months and/or a daily intake of less than 20 calories/kg of body weight.Groups were comparable at baseline in age, sex, tumor type, weight loss, and performance status. A greater percentage of megestrol acetate-treated patients reported appetite improvement and weight gain compared with dronabinol-treated patients: 75% versus 49% (P =.0001) for appetite and 11% versus 3% (P =.02) for > or = 10% baseline weight gain. Combination treatment resulted in no significant differences in appetite or weight compared with megestrol acetate alone. The Functional Assessment of Anorexia/Cachexia Therapy questionnaire, which emphasizes anorexia-related questions, demonstrated an improvement in quality of life (QOL) among megestrol acetate-treated and combination-treated patients. The single-item Uniscale, a global QOL instrument, found comparable scores. Toxicity was also comparable, with the exception of an increased incidence of impotence among men who received megestrol acetate.In the doses and schedules we studied, megestrol acetate provided superior anorexia palliation among advanced cancer patients compared with dronabinol alone. Combination therapy did not appear to confer additional benefit." @default.
- W4242082761 created "2022-05-12" @default.
- W4242082761 creator A5002158560 @default.
- W4242082761 creator A5008767553 @default.
- W4242082761 creator A5013202100 @default.
- W4242082761 creator A5029941846 @default.
- W4242082761 creator A5040261194 @default.
- W4242082761 creator A5043662055 @default.
- W4242082761 creator A5059012052 @default.
- W4242082761 creator A5060700606 @default.
- W4242082761 creator A5063367975 @default.
- W4242082761 creator A5064449830 @default.
- W4242082761 creator A5071316240 @default.
- W4242082761 creator A5072257104 @default.
- W4242082761 date "2002-01-15" @default.
- W4242082761 modified "2023-10-16" @default.
- W4242082761 title "Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study" @default.
- W4242082761 cites W159866590 @default.
- W4242082761 cites W1796184815 @default.
- W4242082761 cites W1925973161 @default.
- W4242082761 cites W1983235754 @default.
- W4242082761 cites W2002240263 @default.
- W4242082761 cites W2016333778 @default.
- W4242082761 cites W2017669133 @default.
- W4242082761 cites W2019012224 @default.
- W4242082761 cites W2023492035 @default.
- W4242082761 cites W2068743551 @default.
- W4242082761 cites W2080633114 @default.
- W4242082761 cites W2090483583 @default.
- W4242082761 cites W2095587092 @default.
- W4242082761 cites W2099266743 @default.
- W4242082761 cites W2137565328 @default.
- W4242082761 cites W2152279931 @default.
- W4242082761 cites W2167090973 @default.
- W4242082761 cites W2177302713 @default.
- W4242082761 cites W2394900716 @default.
- W4242082761 cites W4240763517 @default.
- W4242082761 doi "https://doi.org/10.1200/jco.2002.20.2.567" @default.
- W4242082761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11786587" @default.
- W4242082761 hasPublicationYear "2002" @default.
- W4242082761 type Work @default.
- W4242082761 citedByCount "254" @default.
- W4242082761 countsByYear W42420827612012 @default.
- W4242082761 countsByYear W42420827612013 @default.
- W4242082761 countsByYear W42420827612014 @default.
- W4242082761 countsByYear W42420827612015 @default.
- W4242082761 countsByYear W42420827612016 @default.
- W4242082761 countsByYear W42420827612017 @default.
- W4242082761 countsByYear W42420827612018 @default.
- W4242082761 countsByYear W42420827612019 @default.
- W4242082761 countsByYear W42420827612020 @default.
- W4242082761 countsByYear W42420827612021 @default.
- W4242082761 countsByYear W42420827612022 @default.
- W4242082761 countsByYear W42420827612023 @default.
- W4242082761 crossrefType "journal-article" @default.
- W4242082761 hasAuthorship W4242082761A5002158560 @default.
- W4242082761 hasAuthorship W4242082761A5008767553 @default.
- W4242082761 hasAuthorship W4242082761A5013202100 @default.
- W4242082761 hasAuthorship W4242082761A5029941846 @default.
- W4242082761 hasAuthorship W4242082761A5040261194 @default.
- W4242082761 hasAuthorship W4242082761A5043662055 @default.
- W4242082761 hasAuthorship W4242082761A5059012052 @default.
- W4242082761 hasAuthorship W4242082761A5060700606 @default.
- W4242082761 hasAuthorship W4242082761A5063367975 @default.
- W4242082761 hasAuthorship W4242082761A5064449830 @default.
- W4242082761 hasAuthorship W4242082761A5071316240 @default.
- W4242082761 hasAuthorship W4242082761A5072257104 @default.
- W4242082761 hasConcept C121608353 @default.
- W4242082761 hasConcept C126322002 @default.
- W4242082761 hasConcept C134018914 @default.
- W4242082761 hasConcept C142724271 @default.
- W4242082761 hasConcept C147583825 @default.
- W4242082761 hasConcept C168563851 @default.
- W4242082761 hasConcept C170493617 @default.
- W4242082761 hasConcept C204787440 @default.
- W4242082761 hasConcept C27081682 @default.
- W4242082761 hasConcept C2777704314 @default.
- W4242082761 hasConcept C2778654693 @default.
- W4242082761 hasConcept C2779320873 @default.
- W4242082761 hasConcept C2780320433 @default.
- W4242082761 hasConcept C2780723184 @default.
- W4242082761 hasConcept C2780871563 @default.
- W4242082761 hasConcept C2908858883 @default.
- W4242082761 hasConcept C511355011 @default.
- W4242082761 hasConcept C544821477 @default.
- W4242082761 hasConcept C71924100 @default.
- W4242082761 hasConcept C75908981 @default.
- W4242082761 hasConcept C90924648 @default.
- W4242082761 hasConceptScore W4242082761C121608353 @default.
- W4242082761 hasConceptScore W4242082761C126322002 @default.
- W4242082761 hasConceptScore W4242082761C134018914 @default.
- W4242082761 hasConceptScore W4242082761C142724271 @default.
- W4242082761 hasConceptScore W4242082761C147583825 @default.
- W4242082761 hasConceptScore W4242082761C168563851 @default.
- W4242082761 hasConceptScore W4242082761C170493617 @default.
- W4242082761 hasConceptScore W4242082761C204787440 @default.
- W4242082761 hasConceptScore W4242082761C27081682 @default.
- W4242082761 hasConceptScore W4242082761C2777704314 @default.